Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series
Cosmoderma · 11.08.2026 · 6 · 95
DOI: 10.25259/csdm_78_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cosmoderma, online erschienen am 11.08.2026. Verfasst von Richa Sharma und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Female pattern hair loss (FPHL) is a common cause of progressive hair thinning in women and can be difficult to manage in those with inadequate response to standard therapies. This case series evaluates the efficacy and safety of oral bicalutamide as an adjunct to low-dose oral minoxidil (LDOM) in women with FPHL refractory to minoxidil monotherapy. Thirty women with clinically and trichoscopically confirmed FPHL (Sinclair grade ≥2) who showed no significant improvement after more than six months of LDOM were included. Oral bicalutamide was added at 50 mg twice weekly for one month, then increased to 50 mg on alternate days with regular biochemical monitoring. Response was assessed at six months using standardized photographs and a 7-point rating scale. At six months, 63.3% showed slight improvement and 33.3% moderate improvement; one patient had no change. No adverse effects were observed. Larger prospective studies are needed to confirm long-term safety and efficacy.
Zitieren
APA
Sharma, R., Dhurat, R. S., Kale, G., & Prasanna, H. (2026). Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series. Cosmoderma, 6, 95. https://doi.org/10.25259/csdm_78_2026
Vancouver
Sharma R, Dhurat RS, Kale G, Prasanna H. Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series. Cosmoderma. 2026;6:95. doi:10.25259/csdm_78_2026
BibTeX
@article{Sharma2026,
author = {Sharma, Richa and Dhurat, Rachita S and Kale, Grishma and Prasanna, Harini},
title = {Bicalutamide: A potential new oral anti-androgenic drug for female pattern hair loss - A case series},
journal = {Cosmoderma},
year = {2026},
volume = {6},
pages = {95},
doi = {10.25259/csdm_78_2026}
}
EUVIMED